STAT3 signaling modulates the immune response induced after antigen targeting to conventional type 1 dendritic cells through the DEC205 receptor

Abstract

Conventional dendritic cells (cDC) are a group of antigen-presenting cells specialized in priming T cell responses. In mice, splenic cDC are divided into conventional type 1 DC (cDC1) and conventional type 2 (cDC2). cDC1 are specialized to prime the Th1 CD4+ T cell response, while cDC2 are mainly associated with the induction of follicular helper T cell responses to support germinal center formation. However, the mechanisms that control the functions of cDC1 and cDC2 are not fully understood, especially the signaling pathways that can modulate their ability to promote different CD4+ T cell responses. Here, we targeted a model antigen for cDC1 and cDC2, through DEC205 and DCIR2 receptors, respectively, to study the role of the STAT3 signaling pathway in the ability of these cells to prime CD4+ T cells. Our results show that, in the absence of the STAT3 signaling pathway, antigen targeting to cDC2 induced similar frequencies of Tfh cells between STAT3-deficient mice compared to fully competent mice. On the other hand, Th1 and Th1-like Tfh cell responses were significantly reduced in STAT3-deficient mice after antigen targeting to cDC1 via the DEC205 receptor. In summary, our results indicate that STAT3 signaling does not control the ability of cDC2 to promote Tfh cell responses after antigen targeting via the DCIR2 receptor, but modulates the function of cDC1 to promote Th1 and Th1-like Tfh T cell responses after antigen targeting via the DEC205 receptor.

Mechanisms of mesothelial cell response to viral infections: HDAC1-3 inhibition blocks poly(I:C)-induced type I interferon response and modulates the mesenchymal/inflammatory phenotype

“…Instead, TNF-α secretion, but not IL-1β, was significantly decreased ( Figure 7B ). Interestingly, the reduced phosphorylation of STAT3, which is activated by many cytokines active in inflammation, including IL-6, IL-10, IL-11, and IL-21, suggests impaired cytokine signaling upon HDAC1-3 inhibition ( Sulczewski et al., 2022 ) ( Figure 7C ).…”

Recombinant antigen delivery to dendritic cells as a way to improve vaccine design

“…More recently, we have used antigen targeting to DCs to study in more detail their signaling pathways. We have shown that the canonical signal transducer and activator of transcription 3 (STAT3) pathway regulates the capacity of cDC1s to support CD4+ T cell responses after antigen delivery to the DEC205 receptor, 45 while the STAT6 pathway controls B cell positioning in the germinal centers after antigen delivery to the DCIR2 receptor. 46 Proteins derived from other protozoans have also been targeted to cDCs in vivo.…”

Role of Histone Deacetylase 6 and Histone Deacetylase 6 Inhibition in Colorectal Cancer

“…HDAC6 displays many of its immune-related effects by affecting the STAT3 signaling pathway, which is involved in the development of malignancies and in the induction and maintenance of immune tolerance and inhibition of immune responses [ 46 , 137 ]. STAT3 signaling can be activated with cytokines IL-6, IL-10, IL-21, and TNF that in DCs downregulate the expression of MHC class II and costimulatory molecules, thereby inducing the tolerogenic immune response [ 138 ]. Furthermore, STAT3 plays a key role in suppressing signal transduction mediated by Toll-like receptors (TLRs) in mature phagocytic cells.…”